Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pluri Inc. Director's Dealing 2013

Mar 25, 2013

6990_dirs_2013-03-25_cdd1531b-eba5-4ac3-a702-e52a23108763.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PLURISTEM THERAPEUTICS INC (PSTI)
CIK: 0001158780
Period of Report: 2013-03-21

Reporting Person: BEN-YORAM ISRAEL (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-03-21 Common Stock M 27500 $0.62 Acquired 320208 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-03-21 Stock option (right to buy) $0.62 M 27500 Disposed 2018-10-30 Common Stock (27500) Direct

Footnotes

F1: The options vested as follows: 25% on 4/30/2009 and the remaining options vested monthly, in equal installments over 18 months until 10/30/2010.